MBOT - Microbot Medical Inc

Recent News

REMINDER: Microbot Medical to Highlight FDA 510 ( k ) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference

GlobeNewswire • 6 days, 5 hours ago • score: 0.31

Live Presentation to be Webcast Today at 9am ET Live Presentation to be Webcast Today at 9am ET ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

Microbot Medical Inc., a preclinical medical device company, researches, designs and develops micro-robotic-assisted medical technologies targeting the minimally invasive surgery space. The company is headquartered in Hingham, Massachusetts.

52W High

$4.62

52W Low

$0.85

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

1.22

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-0.89

EV/Revenue (<3 favorable)

N/A

P/S (TTM) (<3 favorable)

N/A

P/B (<3 favorable)

5.85

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

0.02%

Institutions (25–75% balanced)

8.68%

Shares Outstanding

48,513,900

Float

45,545,900

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

Gross Profit (TTM)

EPS (TTM)

-0.58

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

-0.70%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

N/A

Momentum

Value

N/A

Trend

—

Signal Cross

No cross

As of

—